BIOCRYST PHARMACEUTICALS INC

BCRXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$874.8M

▲ 94.1% YoY

Net Income

$263.9M

▲ 396.9% YoY

EPS

$1.21

▲ 381.4% YoY

Cash

$89.7M

▼ 14.3% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.